The Pentagon is introducing mandatory screening for low testosterone in male service members aged 30 and older. This follows an order issued by Defense Secretary Pete Hegseth in recent weeks.
The U.S. Defense Health Agency has published a series of clinical guidelines for conducting these tests. The screening will be carried out during routine medical examinations of service members.
Screening and treatment details
The measures include screening and blood tests for active‑duty personnel and reservists who are 30 and older. Service members diagnosed with hypogonadism or low testosterone levels will be guaranteed additional examinations and treatment, including testosterone replacement therapy if necessary.
In July, Hegseth stated that if treatment is recommended, “the decision to undergo testosterone replacement therapy will remain entirely with the service member”. Male service members under 30 will be offered the option of annual voluntary screening. The guidelines also note that female service members will be asked about symptoms of hormonal imbalance and, if needed, referred for further evaluation.
Purpose of the initiative
In a statement, the U.S. Department of Defense said the initiative aims to “invest in the health of its fighters, improve their efficiency, and maximize the operational readiness of the forces”.
The screening program was launched two and a half months after Hegseth announced the mandatory requirement. He explained this in a video posted on social media titled “The High‑T Department of War” — “The Department of War with High Testosterone”.
According to: ANSA
